Literature DB >> 17175041

Impaired vascular function in patients with Fontan circulation.

Seon Mi Jin1, Chung Il Noh, Eun Jung Bae, Jung Yun Choi, Yong Soo Yun.   

Abstract

BACKGROUND: This study was performed to evaluate the endothelial function in Fontan patients, and to investigate the associated factors which influence the endothelial function in these patients.
METHODS: Flow mediated dilatation (FMD) and nitroglycerin induced dilatation (NG) of the brachial artery, and intima media thickness (IMT) of common carotid artery (CCA) were measured in nonselected Fontan patients (n=44, age 5 to 29 years, median 14 years, 18 females) by means of high-resolution ultrasound according to the standard protocols. The results were compared to age and sex matched controls (n=25, age 5 to 27 years, median 13 years, 10 females).
RESULTS: Fontan patients presented significantly reduced FMD and NG compared with controls (FMD; 6.5+/-2.4 vs. 11.1+/-1.4%, p<0.001, NG; 13.3+/-5.2 vs. 19.4+/-6.2%; p=0.035). Twenty two percent of Fontan patients presented pure endothelial dysfunction, and 34% of patients presented combined endothelial and smooth muscle dysfunction. Although there was no correlation between FMD and IMT, Fontan patients presented increased carotid IMT (0.44+/-0.07 vs. 0.38+/-0.06 mm, p=0.008). In multivariate analysis, duration of exposure to chronic hypoxia was inversely correlated with FMD (p=0.117, hazards ratio=1.294, 95% confidence interval=0.938-1.786). There was higher FMD in patients receiving angiotensin-converting enzyme inhibitors (ACEi) compared with those not receiving ACEi (7.0+/-2.5 vs. 5.5+/-2.2%, p=0.069).
CONCLUSIONS: Endothelial dysfunction is more prevalent in Fontan patients compared with healthy controls, and the previous hypoxia is an independent factor. Although it is not statistically significant, those patients on treatment with ACEi seem to have better endothelial function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175041     DOI: 10.1016/j.ijcard.2006.09.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  16 in total

1.  Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up.

Authors:  Taisto Sarkola; Edgar Jaeggi; Cameron Slorach; Wei Hui; Timothy Bradley; Andrew N Redington
Journal:  Heart Vessels       Date:  2012-02-14       Impact factor: 2.037

2.  Elevated Aortic Augmentation Index in Children Following Fontan Palliation: Evidence of Stiffer Arteries?

Authors:  Deepti P Bhat; Pooja Gupta; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2015-04-02       Impact factor: 1.655

3.  Renal function of patients with a failing Fontan circuit undergoing total cavopulmonary revision surgery.

Authors:  Fatin Sammour; Marcus Haw; John Paisey; Richard Cope; Mike Herbertson; Tony Salmon; Joseph Vettukattil; Mary Rogerson; Varvara Karagkiozaki; Gruschen Veldtman
Journal:  Pediatr Cardiol       Date:  2008-12-04       Impact factor: 1.655

Review 4.  Aortic dilatation in complex congenital heart disease.

Authors:  Koichiro Niwa
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 5.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

6.  Total Cavopulmonary Connection is Superior to Atriopulmonary Connection Fontan in Preventing Thrombus Formation: Computer Simulation of Flow-Related Blood Coagulation.

Authors:  Koichi Sughimoto; Kazuki Okauchi; Diana Zannino; Christian P Brizard; Fuyou Liang; Michiko Sugawara; Hao Liu; Ken-Ichi Tsubota
Journal:  Pediatr Cardiol       Date:  2015-05-31       Impact factor: 1.655

7.  The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers.

Authors:  Page A W Anderson; Roger E Breitbart; Brian W McCrindle; Lynn A Sleeper; Andrew M Atz; Daphne T Hsu; Minmin Lu; Renee Margossian; Richard V Williams
Journal:  Pediatr Cardiol       Date:  2010-10-12       Impact factor: 1.655

8.  Impact of spironolactone on endothelial function in patients with single ventricle heart.

Authors:  William T Mahle; Alicia Wang; Arshed A Quyyumi; Michael E McConnell; Wendy M Book
Journal:  Congenit Heart Dis       Date:  2009 Jan-Feb       Impact factor: 2.007

9.  Effect of Inhaled Nitric Oxide on Blood Flow Dynamics in Patients After the Fontan Procedure Using Cardiovascular Magnetic Resonance Flow Measurements.

Authors:  Heiner Latus; Bettina Gerstner; Gunter Kerst; Axel Moysich; Kerstin Gummel; Christian Apitz; Juergen Bauer; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-11-07       Impact factor: 1.655

Review 10.  Impact of Health Status and Lifestyle Modifications on Vascular Structure and Function in Children and Adolescents.

Authors:  Donald R Dengel; Justin R Ryder
Journal:  Am J Lifestyle Med       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.